Active Pharmaceutical Ingredients (APIs) are the building blocks in the pharmaceutical industry. India is fast emerging as a powerhouse of API production. According to industry reports, the upcoming and mid-cap API manufacturers in the country increasingly favour trying the litmus test in the European capitals first before taking on the most lucrative and the most challenging US market. As a result, all our plants are built as per regulatory requirements of USFDA and EDQM.
Indoco’s strategy is to gradually move up its value chain and “Integrate Backward” into API business and hence change its role from a 'Contract Manufacturer of Finished Dosage Forms' to be a 'Complete Solutions Provider'. This will allow Indoco to exercise complete control on the supply chain and emerge as a preferred partner for global companies.
Indoco is one of the fastest growing manufacturers and exporters of APIs and Advance Drug Intermediates. Our four state of the art manufacturing facilities offer products from gram to multi-ton levels.
MULTI-TON PLANT
Multipurpose facility to manufacture API's for regulated
markets
Designed to meet cGMP, EDQM and USFDA standards
Two Independent Pharma manufacturing Zones
Reactors (SS and GLR) capacity from 500 L to 4000 L
1000 L Hydrogenation facility
State of the art micronization Set-up
THE KILO
PLANT
USFDA / EDQM approvable small volume high value API's
manufacturing facility
Smooth technology transfer from R & D to commercial level
Designed to manufacture developmental and preclinical
compounds under cGMP
Reactor capacities from 16 L to 500 L
Purified Water System as per USP standards
Clean Room Area - Air Quality: Class 1,00,000 FS 209 D
Hydrogenation Facility: 2 L and 50 L
Operating Temperature Range: - 55°C to 250°C
MID-VOLUME
PLANT
Dedicated Multi product facility to manufacture API's from 100
Kgs to 2000 Kgs
Designed to meet cGMP, EDQM and USFDA standards
Reactor (SS and GLR) capacities from 500 L to 2000 L
INTERMEDIATE PLANT
Multipurpose facility to manufacture advance intermediate and
API's for Emerging markets
Designed to meet Local GMP and WHO:GMP standards
Reactor (SS and GLR) capacities from 500 L to 4000 L